Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital …

A Hernandez-Madrid, T Paul, D Abrams, PF Aziz… - EP …, 2018 - academic.oup.com
The population of patients with congenital heart disease (CHD) is continuously increasing
with more and more patients reaching adulthood. A significant portion of these young adults …

Risk stratification for sudden cardiac death in non-ischaemic dilated cardiomyopathy

M Akhtar, PM Elliott - Current cardiology reports, 2019 - Springer
Abstract Purpose of Review Non-ischaemic dilated cardiomyopathy (DCM) occurs in 1 in
2500 individuals in the general population and is associated with considerable morbidity …

Implant and midterm outcomes of the subcutaneous implantable cardioverter-defibrillator registry: the EFFORTLESS study

L Boersma, C Barr, R Knops, D Theuns… - Journal of the American …, 2017 - jacc.org
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was
developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads …

Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure

MB Elming, JC Nielsen, J Haarbo, L Videbæk… - Circulation, 2017 - Am Heart Assoc
Background: The DANISH study (Danish Study to Assess the Efficacy of ICDs [Implantable
Cardioverter Defibrillators] in Patients With Non-Ischemic Systolic Heart Failure on Mortality) …

[HTML][HTML] Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results

MR Gold, JD Aasbo, MF El-Chami, M Niebauer, J Herre… - Heart rhythm, 2017 - Elsevier
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …

Risk factors and temporal trends of complications associated with transvenous implantable cardiac defibrillator leads

JN Koneru, PW Jones, EF Hammill, N Wold… - Journal of the …, 2018 - Am Heart Assoc
Background The transvenous implantable cardioverter‐defibrillator (ICD) lead is the most
common source of complications in a traditional ICD system. This investigation aims to …

Myocardial fibrosis and the effect of primary prophylactic defibrillator implantation in patients with non-ischemic systolic heart failure—DANISH-MRI

MB Elming, S Hammer-Hansen, I Voges, E Nyktari… - American Heart …, 2020 - Elsevier
Aims Patients with non-ischemic systolic heart failure have an increased risk of sudden
cardiac death (SCD). Myocardial fibrosis, detected as late gadolinium enhancement (LGE) …

Long-term risk for device-related complications and reoperations after implantable cardioverter-defibrillator implantation: an observational cohort study

I Ranasinghe, CS Parzynski, JV Freeman… - Annals of internal …, 2016 - acpjournals.org
Background: Long-term nonfatal outcomes after implantable cardioverter-defibrillator (ICD)
placement are poorly defined. Objective: To determine the long-term risk for ICD-related …

Limitations of randomized clinical trials

JB Kostis, JM Dobrzynski - The American journal of cardiology, 2020 - Elsevier
Randomized clinical trials are essential for determining the efficacy of interventions, but
have limitations. The types of limitations discussed in this review may be grouped in 11 …

[HTML][HTML] Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction

L Boersma, MC Burke, P Neuzil, P Lambiase… - Heart Rhythm, 2016 - Elsevier
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) provides an
alternative to the transvenous implantable cardioverter-defibrillator (TV-ICD). Patients …